Therefore, future in vivo studies might test the prophylactic effect of oxysterol treatment on the severity of Staphylococcus aureus infection, as well as infections caused by bacteria producing cholesterol-dependent cytolysins. This evidence concerns the gene PRF1 and staphylococcus aureus infection.